Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epicardial adipose tissue in contemporary cardiology
Gianluca Iacobellis
Nature Reviews Cardiology (2022) Vol. 19, Iss. 9, pp. 593-606
Open Access | Times Cited: 380

Showing 1-25 of 380 citing articles:

Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
A. Michael Lincoff, Kirstine Brown‐Frandsen, Helen M. Colhoun, et al.
New England Journal of Medicine (2023) Vol. 389, Iss. 24, pp. 2221-2232
Open Access | Times Cited: 1034
Perivascular adipose tissue as a source of therapeutic targets and clinical biomarkers
Charalambos Antoniades, Dimitris Tousoulis, Marija Vavlukis, et al.
European Heart Journal (2023) Vol. 44, Iss. 38, pp. 3827-3844
Open Access | Times Cited: 80
Omentin1 ameliorates myocardial ischemia-induced heart failure via SIRT3/FOXO3a-dependent mitochondrial dynamical homeostasis and mitophagy
Jingui Hu, Tao Liu, Fei Fu, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 73
Gut microbiota in overweight and obesity: crosstalk with adipose tissue
Patrice D. Cani, Matthias Van Hul
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 21, Iss. 3, pp. 164-183
Closed Access | Times Cited: 46
Obesity and cardiovascular disease: an ESC clinical consensus statement
Konstantinos C. Koskinas, Emeline M. Van Craenenbroeck, Charalambos Antoniades, et al.
European Heart Journal (2024)
Open Access | Times Cited: 46
Role of Cardiovascular Imaging in Risk Assessment: Recent Advances, Gaps in Evidence, and Future Directions
Francesco Perone, Marco Bernardi, Alban Redheuil, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 17, pp. 5563-5563
Open Access | Times Cited: 45
Efficacy of cardiometabolic drugs in reduction of epicardial adipose tissue: a systematic review and meta-analysis
Veronika A. Myasoedova, Valentina Parisi, Donato Moschetta, et al.
Cardiovascular Diabetology (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 43
Atrial Cardiomyopathy Revisited - Evolution of a Concept. A Clinical Consensus Statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), the Asian Pacific Heart Rhythm Association (APHRS), and the Latin American Heart Rhythm Society (LAHRS)
Andreas Goette, Domenico Corradi, Dobromir Dobrev, et al.
EP Europace (2024) Vol. 26, Iss. 9
Open Access | Times Cited: 40
Obesity, dyslipidemia, and cardiovascular disease: A joint expert review from the Obesity Medicine Association and the National Lipid Association 2024
Harold Bays, Carol F. Kirkpatrick, Kevin C. Maki, et al.
Journal of clinical lipidology (2024) Vol. 18, Iss. 3, pp. e320-e350
Open Access | Times Cited: 25
Cardiovascular Significance and Genetics of Epicardial and Pericardial Adiposity
Joel Rämö, Shinwan Kany, Cody R. Hou, et al.
JAMA Cardiology (2024) Vol. 9, Iss. 5, pp. 418-418
Closed Access | Times Cited: 22
Obesity, dyslipidemia, and cardiovascular disease: A joint expert review from the Obesity Medicine Association and the National Lipid Association 2024
Harold Bays, Carol F. Kirkpatrick, Kevin C. Maki, et al.
Obesity Pillars (2024) Vol. 10, pp. 100108-100108
Open Access | Times Cited: 19
Adipose tissue as a linchpin of organismal ageing
Tammy Nguyen, Silvia Corvera
Nature Metabolism (2024) Vol. 6, Iss. 5, pp. 793-807
Closed Access | Times Cited: 18
The Effect of Semaglutide on Mortality and COVID-19–Related Deaths
Benjamin M. Scirica, A. Michael Lincoff, Ildiko Lingvay, et al.
Journal of the American College of Cardiology (2024) Vol. 84, Iss. 17, pp. 1632-1642
Open Access | Times Cited: 18
AI-derived epicardial fat measurements improve cardiovascular risk prediction from myocardial perfusion imaging
Robert J.H. Miller, Aakash Shanbhag, Aditya Killekar, et al.
npj Digital Medicine (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 16
Metabolic remodelling in atrial fibrillation: manifestations, mechanisms and clinical implications
David Bode, Julius Ryan D. Pronto, Gabriele G. Schiattarella, et al.
Nature Reviews Cardiology (2024) Vol. 21, Iss. 10, pp. 682-700
Closed Access | Times Cited: 16
Obesity and cardiovascular disease: an ESC clinical consensus statement
Konstantinos C. Koskinas, Emeline M. Van Craenenbroeck, Charalambos Antoniades, et al.
European Journal of Preventive Cardiology (2024)
Open Access | Times Cited: 16
Human epicardial adipose tissue expresses glucose-dependent insulinotropic polypeptide, glucagon, and glucagon-like peptide-1 receptors as potential targets of pleiotropic therapies
Alexis Elias Malavazos, Gianluca Iacobellis, Elena Dozio, et al.
European Journal of Preventive Cardiology (2023) Vol. 30, Iss. 8, pp. 680-693
Open Access | Times Cited: 39
The heterocellular heart: identities, interactions, and implications for cardiology
Achim Lother, Peter Köhl
Basic Research in Cardiology (2023) Vol. 118, Iss. 1
Open Access | Times Cited: 28
Impact of Obesity on Atrial Fibrillation Pathogenesis and Treatment Options
Rina Sha, Olivia Baines, Abbie Hayes, et al.
Journal of the American Heart Association (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 27
Effects of SGLT-2 inhibitors on adipose tissue distribution in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials
Xianghong Wang, Niujian Wu, Chuanchuan Sun, et al.
Diabetology & Metabolic Syndrome (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 26
Targeting the Substrate for Atrial Fibrillation
Mark McCauley, Gianluca Iacobellis, Na Li, et al.
Journal of the American College of Cardiology (2024) Vol. 83, Iss. 20, pp. 2015-2027
Closed Access | Times Cited: 15
Impact of epicardial adipose tissue on cardiac function and morphology in patients with diastolic dysfunction
Alexander Schulz, Sören J. Backhaus, Torben Lange, et al.
ESC Heart Failure (2024) Vol. 11, Iss. 4, pp. 2013-2022
Open Access | Times Cited: 12
New Therapeutic Approaches for the Treatment of Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Increased Cardiovascular Risk
Marija Branković, Marija Dukić, Tijana Gmizić, et al.
Diagnostics (2024) Vol. 14, Iss. 2, pp. 229-229
Open Access | Times Cited: 11
Epicardial Adipose Tissue and Heart Failure, Friend or Foe?
Dong‐Hyuk Cho, Seong‐Mi Park
Diabetes & Metabolism Journal (2024) Vol. 48, Iss. 3, pp. 373-384
Open Access | Times Cited: 11
Epicardial adipose tissue as an independent predictor of long-term outcome in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement
Alexander Schulz, Bo Eric Beuthner, Zoé M. Böttiger, et al.
Clinical Research in Cardiology (2024)
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top